Boston Scientific Corporation Natick, Massachusetts
Boston Scientific Corporation (NYSE: BSX) is the world's largest medical device company dedicated to less-invasive therapies. The Company's products and technologies are designed to reduce risk, trauma, cost, procedure time and the need for aftercare. These products and technologies are generally used for enlarging narrowed blood vessels to prevent heart attack and stroke, clearing passages blocked by plaque to alleviate pain, opening obstructions and bringing relief to patients suffering from various forms of cancer, performing biopsies and ultrasounds, mapping electrical problems in the heart, placing filters to prevent blood clots from reaching the lungs, heart or brain, and treating urological, renal, pulmonary, cerebrovascular and gastrointestinal diseases.
Celsion Corporation 10220-I Old Columbia Rd Columbia, Maryland 21046
Celsion is dedicated to applying its proprietary focused heat technology to the development and commercialization of treatments for cancer and other diseases. It is currently in late stage clinical development of innovative medical devices to treat both Benign Prostatic Hyperplasia (BPH), a prostate condition common in men over age 55, and breast cancer and is working with Duke University and Memorial Sloan-Kettering on the development of new heat-activated drugs and gene therapies. In January 2003, Celsion entered into a strategic alliance with Boston Scientific Corporation (NYSE:BSX) in which Boston Scientific will initially distribute Celsion’s BPH product worldwide. Email: investorrelations@celsion.com
Guidant Corporation Indianapolis, Indiana
Guidant is a world leader in the design and development of cardiovascular medical products. Our devices help patients with heart disease return to active and productive lives. We provide physicians with leading-edge technologies for improved patient management and clinical outcomes. And we’ve created a culture in which employees, investors and our communities share in our success. Note: Guidant Corporation merger with Boston Scientific Corporation closed on April 21, 2006.